Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IL23R | Q5VWK5 | 17/20 | 0.56 |
| ▸ | BACE1 | P56817 | 1/20 | 0.50 |
| ▸ | BACE2 | Q9Y5Z0 | 1/20 | 0.50 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.50 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.50 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29531748 | 0.88 | OPRD1 (0.53) | IL23ROPRM1OPRD1OPRK1 | |
| SCHEMBL30906438 | 0.88 | OPRL1 (0.55) | BACE1BACE2 | |
| SCHEMBL30906554 | 0.88 | OPRL1 (0.57) | BACE1 | |
| SCHEMBL31243862 | 0.87 | OPRD1 (0.58) | IL23ROPRM1OPRD1OPRK1 | |
| SCHEMBL30974333 | 0.87 | F2 (0.60) | BACE1OPRM1OPRD1OPRK1 | |
| SCHEMBL31243890 | 0.87 | OPRM1 (0.57) | IL23ROPRM1OPRD1OPRK1 | |
| SCHEMBL30906334 | 0.87 | OPRL1 (0.59) | BACE1OPRM1OPRD1OPRK1 | |
| SCHEMBL31243949 | 0.87 | OPRD1 (0.61) | OPRM1OPRD1OPRK1 | |
| SCHEMBL30792551 | 0.86 | TFPI (0.55) | IL23RBACE1BACE2OPRD1 | |
| SCHEMBL30792550 | 0.86 | TFPI (0.55) | IL23RBACE1BACE2OPRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4598964-A2 | ANTI-IGE ANTIBODIES | Abwiz Bio, Inc. (US) | 2025-08-13 | — | — | EP | disclosed |
| US-20240182599-A1 | ANTI-IGE ANTIBODIES | ABWIZ BIO, INC. | 2024-06-06 | — | — | US | disclosed |
| WO-2024076785-A2 | ANTI-IGE ANTIBODIES | ABWIZ BIO, INC. (US) | 2024-04-11 | — | — | WO | disclosed |